Bellevue Life Sciences Acquisition Corp.Bellevue Life Sciences Acquisition Corp.Bellevue Life Sciences Acquisition Corp.

Bellevue Life Sciences Acquisition Corp.

No trades
See on Supercharts
Market capitalization
‪60.22 M‬USD
‪403.78 K‬USD
‪2.81 M‬
Beta (1Y)
0.04

About Bellevue Life Sciences Acquisition Corp.

Sector
CEO
Guk-Hyun Hwang
Headquarters
Bellevue
Employees (FY)
2
Founded
2020
FIGI
BBG01752PPQ2
Bellevue Life Sciences Acquisition Corp. is a blank check company. Its objectives are to enter into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or similar business combination with one or more businesses. The company was founded on February 25, 2020 and is headquartered in Bellevue, WA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of BLAC is 10.71 USD — it has decreased by 0.07% in the past 24 hours. Watch Bellevue Life Sciences Acquisition Corp. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Bellevue Life Sciences Acquisition Corp. stocks are traded under the ticker BLAC.
BLAC stock is 0.17% volatile and has beta coefficient of 0.04. Track Bellevue Life Sciences Acquisition Corp. stock price on the chart and check out the list of the most volatile stocks — is Bellevue Life Sciences Acquisition Corp. there?
Yes, you can track Bellevue Life Sciences Acquisition Corp. financials in yearly and quarterly reports right on TradingView.
BLAC stock has fallen by 0.17% compared to the previous week, the month change is a 0.11% rise, over the last year Bellevue Life Sciences Acquisition Corp. has showed a 5.54% increase.
BLAC net income for the last quarter is ‪−86.17 K‬ USD, while the quarter before that showed ‪78.18 K‬ USD of net income which accounts for −210.22% change. Track more Bellevue Life Sciences Acquisition Corp. financial stats to get the full picture.
No, BLAC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BLAC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Bellevue Life Sciences Acquisition Corp. stock right from TradingView charts — choose your broker and connect to your account.
BLAC reached its all-time high on Nov 13, 2023 with the price of 11.16 USD, and its all-time low was 10.07 USD and was reached on Mar 20, 2023. View more price dynamics on BLAC chart.
See other stocks reaching their highest and lowest prices.
As of May 7, 2024, the company has 2.00 employees. See our rating of the largest employees — is Bellevue Life Sciences Acquisition Corp. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Bellevue Life Sciences Acquisition Corp. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Bellevue Life Sciences Acquisition Corp. stock shows the neutral signal. See more of Bellevue Life Sciences Acquisition Corp. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.